يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Minisini A. M."', وقت الاستعلام: 0.70s تنقيح النتائج
  1. 1
    دورية أكاديمية
    First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study

    المؤلفون: Basile D., Gerratana L., Corvaja C., Pelizzari G., Franceschin G., Bertoli E., Palmero L., Zara D., Alberti M., Buriolla S., Da Ros L., Bonotto M., Mansutti M., Spazzapan S., Cinausero M., Minisini A. M., Fasola G., Puglisi F.

    المساهمون: Basile, D., Gerratana, L., Corvaja, C., Pelizzari, G., Franceschin, G., Bertoli, E., Palmero, L., Zara, D., Alberti, M., Buriolla, S., Da Ros, L., Bonotto, M., Mansutti, M., Spazzapan, S., Cinausero, M., Minisini, A. M., Fasola, G., Puglisi, F.

    مصطلحات موضوعية: CDK4/6 inhibitor, MBC, Metastatic luminal breast cancer, Treatment strategies

    العلاقة: volume:57; firstpage:104; lastpage:112; numberofpages:9; journal:THE BREAST; http://hdl.handle.net/11390/1207516Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85104980676

    الإتاحة: https://doi.org/10.1016/j.breast.2021.02.015Test
    http://hdl.handle.net/11390/1207516Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial

    المؤلفون: Galardi, Francesca, De Luca, Francesca, Biagioni, Chiara, Migliaccio, Ilenia, Curigliano, Giuseppe, Minisini, Alessandro M, Bonechi, Martina, Moretti, Erica, Risi, Emanuela, McCartney, Amelia, Benelli, Matteo, Romagnoli, Dario, Cappadona, Silvia, Gabellini, Stefano, Guarducci, Cristina, Conti, Valerio, Biganzoli, Laura, Di Leo, Angelo, Malorni, Luca

    المساهمون: F. Galardi, F. De Luca, C. Biagioni, I. Migliaccio, G. Curigliano, A.M. Minisini, M. Bonechi, E. Moretti, E. Risi, A. Mccartney, M. Benelli, D. Romagnoli, S. Cappadona, S. Gabellini, C. Guarducci, V. Conti, L. Biganzoli, A. Di Leo, L. Malorni

    مصطلحات موضوعية: Biomarker, CDK4/6 inhibitor, CTC, Liquid biopsy, Luminal breast cancer, Metastatic, Palbociclib, ddPCR, Settore MED/06 - Oncologia Medica

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33761970; info:eu-repo/semantics/altIdentifier/wos/WOS:000634797700002; volume:23; issue:1; numberofpages:12; journal:BREAST CANCER RESEARCH; http://hdl.handle.net/2434/828433Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85103354230

    الإتاحة: https://doi.org/10.1186/s13058-021-01415-wTest
    http://hdl.handle.net/2434/828433Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial

    المؤلفون: Rossi L., Biagioni C., McCartney A., Migliaccio I., Curigliano G., Sanna G., Moretti E., Minisini A. M., Cinieri S., Tondini C., Arpino G., Bernardo A., Martignetti A., Risi E., Pestrin M., Boni L., Benelli M., Biganzoli L., Di Leo A., Malorni L.

    المساهمون: Rossi, L., Biagioni, C., Mccartney, A., Migliaccio, I., Curigliano, G., Sanna, G., Moretti, E., Minisini, A. M., Cinieri, S., Tondini, C., Arpino, G., Bernardo, A., Martignetti, A., Risi, E., Pestrin, M., Boni, L., Benelli, M., Biganzoli, L., Di Leo, A., Malorni, L.

    مصطلحات موضوعية: Best sequence, CDK4/6 inhibitor, Metastatic breast cancer, Palbociclib, TREnd trial, Antineoplastic Agents, Hormonal, Antineoplastic Combined Chemotherapy Protocol, Breast Neoplasm, Female, Human, Kaplan-Meier Estimate, Piperazine, Postmenopause, Prognosi, Pyridine, Receptor, ErbB-2, Receptors, Estrogen, Progesterone, Treatment Outcome

    العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000469474800001; volume:21; issue:1; firstpage:71; journal:BREAST CANCER RESEARCH; http://hdl.handle.net/11588/848496Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85066816663

    الإتاحة: https://doi.org/10.1186/s13058-019-1149-5Test
    http://hdl.handle.net/11588/848496Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial

    المؤلفون: Malorni, L., Curigliano, G., Minisini, A. M., Cinieri, S., Tondini, C. A., D'Hollander, K., Arpino, G., Bernardo, A., Martignetti, A., Criscitiello, C., Puglisi, F., Pestrin, M., Sanna, G., Moretti, E., Risi, E., Biagioni, C., McCartney, A., Boni, L., Buyse, M., Migliaccio, I., Biganzoli, L., Di Leo, A.

    المساهمون: L. Malorni, G. Curigliano, A.M. Minisini, S. Cinieri, C.A. Tondini, K. D'Hollander, G. Arpino, A. Bernardo, A. Martignetti, C. Criscitiello, F. Puglisi, M. Pestrin, G. Sanna, E. Moretti, E. Risi, C. Biagioni, A. Mccartney, L. Boni, M. Buyse, I. Migliaccio, L. Biganzoli, A. Di Leo

    مصطلحات موضوعية: Advanced breast cancer, CDK4/6 inhibitor, Endocrine resistance, Palbociclib, Hematology, Oncology, Settore MED/06 - Oncologia Medica

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29893790; info:eu-repo/semantics/altIdentifier/wos/WOS:000442277600021; volume:29; issue:8; firstpage:1748; lastpage:1754; numberofpages:7; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/2434/623223Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85053871122

    الإتاحة: https://doi.org/10.1093/annonc/mdy214Test
    http://hdl.handle.net/2434/623223Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث